Ron Squarer
2017
In 2017, Ron Squarer earned a total compensation of $4.7M as Chief Executive Officer at Array BioPharma, a 139% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $402,127 |
|---|---|
| Option Awards | $2,845,285 |
| Salary | $600,010 |
| Stock Awards | $824,063 |
| Other | $52,000 |
| Total | $4,723,485 |
Squarer received $2.8M in option awards, accounting for 60% of the total pay in 2017.
Squarer also received $402.1K in non-equity incentive plan, $600K in salary, $824.1K in stock awards and $52K in other compensation.
Rankings
In 2017, Ron Squarer's compensation ranked 2,047th out of 14,666 executives tracked by ExecPay. In other words, Squarer earned more than 86.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,047 out of 14,666 | 86th |
Division Manufacturing | 700 out of 5,770 | 88th |
Major group Chemicals And Allied Products | 189 out of 2,074 | 91st |
Industry group Drugs | 142 out of 1,730 | 92nd |
Industry Pharmaceutical Preparations | 109 out of 1,329 | 92nd |
Source: SEC filing on September 13, 2017.
Squarer's colleagues
We found five more compensation records of executives who worked with Ron Squarer at Array BioPharma in 2017.